Entries by Akesogen Admin

For the Third Year in a Row AKESOgen makes Annual List of America’s Fastest-Growing Private Companies—the Inc.500

AKESOgen Ranks as the No. 33 Healthcare Company and 448th Overall on the 2017 Inc.500 NEW YORK and ATLANTA August 16, 2017 – Inc. magazine today ranked AKESOgen, 33rd as a Healthcare company and 448th overall on its 36th annual Inc. 500, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

Emory and AKESOgen Partner on Healthy Aging Study

ATLANTA February 28, 2016 – Emory University School of Medicine and AKESOgen announced today their collaboration on the Emory Healthy Aging Study. The largest clinical research study ever conducted in Atlanta, the Emory Healthy Aging Study is a game changing effort to further the scientific understanding of how we age. Aiming to identify predictive markers […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

AKESOgen delegates attend and present at ASHG in Vancouver

AKESOgen exhibited and presented at the American Society of Human Genetics 2016 Annual Meeting in Vancouver, Canada, October 18th – 22nd. Dr. Bouzyk presented novel genotyping solutions for large scale genotyping studies. We invite you learn more about our genomics solutions in: Research Services Clinical Diagnostics Services Clinical Trials Services by contacting us at 770 542 0890 […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

For the Second Consecutive Year AKESOgen makes Annual List of America’s Fastest-Growing Private Companies—the Inc.500

AKESOgen Ranks as the No. 23 Healthcare Company and 240th Overall on the 2016 Inc.500 with Three-Year Sales Growth of 1,615%   NEW YORK and ATLANTA August 17, 2016 – Inc. magazine today ranked AKESOgen, 23rd as a Healthcare company and 240th overall on its 35th annual Inc. 500, the most prestigious ranking of the nation’s […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

AKESOgen Receives Accreditation from College of American Pathologists

Atlanta, GA – 8th February 2016 – Personalized Medicine and genomics company AKESOgen, announced today Accreditation from the College of American Pathologists (CAP). The AKESOgen facility in Atlanta completed a comprehensive on-site inspection and analysis of its oncology testing as part of the CAP’s Accreditation Programs. The CAP Laboratory Accreditation Program involves a process of […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer Brian Leyland-Jones, Kathryn P. Gray, Mark Abramovitz, Mark Bouzyk, Brandon Young, Bradley Long, Roswitha Kammler, Patrizia Dell’Orto, Beat Thürlimann, Vernon Harvey, Patrick Neven, Laurent Arnould, Rudolf Maibach, Karen N. Price, Alan S. Coates, Aron […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

AKESOgen’s CSO wins prestigious Innovation Award at the Annual Partnership Gwinnett Summit

  Atlanta, GA – 11th December 2015 – Dr. Bouzyk, a nominated finalist, was today announced as the Winner of the “Innovation” category for the Annual Partnership Gwinnett Awards. The winners were announced at the Awards Luncheon during the Annual Partnership Gwinnett Summit at Georgia Gwinnett College. Preceding the luncheon a half-day program focused on […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

AKESOgen makes Annual List of America’s Fastest-Growing Private Companies—the Inc.500

AKESOgen makes Annual List of America’s Fastest-Growing Private Companies—the Inc.500 AKESOgen Ranks as the No. 44 Healthcare Company and 363rd Overall on the 2015 Inc.500 with Three-Year Sales Growth of 1,300% NEW YORK and ATLANTA, August 12, 2015 — Inc. magazine today ranked the genomics services provider, AKESOgen, 44th as a Healthcare company and 363rd overall on […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

AKESOgen to host and sponsor Industry tour on behalf of Georgia Bio

Please join Georgia Bio’s Emerging Leaders Network on their Industry Tour for an inside look of AKESOgen, a premier provider of genetic analysis. This industry tour will provide participants an inside look of AKESOgen, a leader in personalized medicine and genomics.  Equipped with industry experts, AKESOgen provides high quality genomic analysis services, performing over 21,000 whole genome […]

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail